BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30612029)

  • 1. Synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes: A small modification at tetrazole C5 markedly influences the in vivo antitumor efficacy.
    Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
    J Inorg Biochem; 2019 Mar; 192():82-86. PubMed ID: 30612029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient uptake into cisplatin-resistant cells and the isomerization upon coordinative DNA binding of anticancer tetrazolato-bridged dinuclear platinum(II) complexes.
    Uemura M; Hoshiyama M; Furukawa A; Sato T; Higuchi Y; Komeda S
    Metallomics; 2015 Nov; 7(11):1488-96. PubMed ID: 26393664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific Conformational Change in Giant DNA Caused by Anticancer Tetrazolato-Bridged Dinuclear Platinum(II) Complexes: Middle-Length Alkyl Substituents Exhibit Minimum Effect.
    Komeda S; Yoneyama H; Uemura M; Muramatsu A; Okamoto N; Konishi H; Takahashi H; Takagi A; Fukuda W; Imanaka T; Kanbe T; Harusawa S; Yoshikawa Y; Yoshikawa K
    Inorg Chem; 2017 Jan; 56(2):802-811. PubMed ID: 28045514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vivo highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex largely circumvents in vitro cisplatin resistance: two linkage isomers yield the same product upon reaction with 9-ethylguanine but exhibit different cytotoxic profiles.
    Uemura M; Suzuki T; Nishio K; Chikuma M; Komeda S
    Metallomics; 2012 Jul; 4(7):686-92. PubMed ID: 22473092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of Fluorine into Antitumor-Active Dinuclear Platinum(II) Complexes Leads to Modulation of
    Uemura M; Hiramoto K; Yoneyama H; Harusawa S; Komeda S
    Inorg Chem; 2022 Aug; 61(31):12155-12164. PubMed ID: 35876345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient DNA compaction mediated by an in vivo antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
    Yoshikawa Y; Komeda S; Uemura M; Kanbe T; Chikuma M; Yoshikawa K; Imanaka T
    Inorg Chem; 2011 Nov; 50(22):11729-35. PubMed ID: 22004345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
    Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
    J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.
    Kishimoto S; Yasuda M; Suzuki R; Fukushima S
    Biometals; 2016 Dec; 29(6):1075-1083. PubMed ID: 27787693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of and platinum(II) migration in the reactions of tetrazolato-bridged dinuclear platinum(II) complexes with nucleotides.
    Uemura M; Komeda S
    J Inorg Biochem; 2017 Dec; 177():359-367. PubMed ID: 28893417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H; Gou S; Wang Z; Chen F; Fang L
    Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(IV) Complexes of
    Papadia P; Micoli K; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
    Imai R; Komeda S; Shimura M; Tamura S; Matsuyama S; Nishimura K; Rogge R; Matsunaga A; Hiratani I; Takata H; Uemura M; Iida Y; Yoshikawa Y; Hansen JC; Yamauchi K; Kanemaki MT; Maeshima K
    Sci Rep; 2016 Apr; 6():24712. PubMed ID: 27094881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data on synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes.
    Komeda S; Yoneyama H; Uemura M; Tsuchiya T; Hoshiyama M; Sakazaki T; Hiramoto K; Harusawa S
    Data Brief; 2022 Feb; 40():107697. PubMed ID: 34993284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.